Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
docetaxel (taxotere) (2 trials)
olanzapine (zyprexa) (1 trial)
oxaliplatin (eloxatin) (2 trials)
paclitaxel (taxol) (1 trial)
ramucirumab (cyramza) (1 trial)
trastuzumab (herceptin) (1 trial)
Biliary Tract Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Large Cell (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Stomach Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (6 total)